Atorvastatin
Active ingredient description
Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Medicines
Atorvastatin is the active ingredient of these drugs:
Lithuania
South Africa
Ecuador
South Africa
South Africa
Cyprus
Ecuador
Italy
South Africa
Estonia Lithuania
South Africa
Brazil
Hong Kong
Singapore
Brazil
Estonia
Singapore
Austria
Finland
Estonia Lithuania
Estonia Germany Hong Kong Italy Lithuania
Ecuador
Hong Kong
Brazil
Hong Kong
Austria
Singapore
Cyprus
Australia
Austria
Poland
Austria
Brazil Poland
Tunisia
Austria
Singapore
Poland
Poland
Hong Kong
Ecuador
Poland
Ecuador
Tunisia
Poland
Singapore
Ecuador
Singapore
Hong Kong
Poland
Austria
Hong Kong
Spain
Hong Kong
Tunisia
South Africa
Brazil
Brazil
Poland
Cyprus
South Africa
Hong Kong
South Africa
Singapore
Ecuador
Ecuador
South Africa
Singapore
South Africa
Hong Kong
Italy
Brazil
Cyprus Poland
Tunisia
Poland
Hong Kong
South Africa
Ecuador
Ecuador
Ecuador
Hong Kong
Hong Kong
Hong Kong
Brazil
Hong Kong
South Africa
Finland Hong Kong
Brazil
Australia Brazil Canada Cyprus Ecuador
Hong Kong
Hong Kong
Ecuador
South Africa
Hong Kong
Ecuador
Ecuador
South Africa
Brazil
Estonia Lithuania
Australia New Zealand
Brazil
Italy
Lithuania
Poland
Italy
Finland
Hong Kong
Spain
Ecuador
Italy
Austria Estonia Germany Lithuania Poland
Tunisia
Ecuador Poland
Hong Kong
France Tunisia
Tunisia
Italy
Spain
Cyprus Estonia Lithuania Poland
Italy
Poland Singapore
Lithuania
Italy
Australia
Hong Kong Singapore
Brazil
Italy
Italy
Ecuador
Australia
Estonia Poland Singapore
South Africa
Hong Kong
Brazil Ecuador
South Africa
Hong Kong
Hong Kong
New Zealand Spain
Ecuador
Atorvastatin is also found within below combination drugs:
ACROVASTIN AMLO , ACROZETIM , AMALORIS , AMLATOR , AMLOSATIN , AMSTADIN , ANCILLEG , ASTUCOR , ATORDAPIN , ATORIMIB , ATORMIBE , ATORVALAN COMP , ATOZET , ATROLIP PLUS , CADIVAST , CADUET , CODUWON , COLMIBE , DUPLECOR , EUVASCOR , EXTROTAN , EZEATO , EZETAST , EZEVAST , LIPERCOSYL , LIPERTANCE , LIPOMEGA , LIPONORM PLUS , LIPTA , LIPTRUZET , MIZETAM , NONAZET , NORVASTOR , ORVATEZ , PARVAXOR , RASERVAS , RESELIP , TACERNOL , TIAZOMET A , TORVAZIN PLUS , TORZELIP , TRINOMIA , TRIVERAM , TULIP COMBO , ZENTASTA
Product monographs
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):
Structural formula
3D molecular structure
Unique ingredient identifier (UNII)
A0JWA85V8F - ATORVASTATIN
CAS registry number
134523-00-5 - atorvastatin
SNOMED-CT
373444002 - Atorvastatin (substance)